FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2154462017> ?p ?o ?g. }

• W2154462017 endingPage "264" @default.
• W2154462017 startingPage "259" @default.
• W2154462017 abstract "Cytotoxic drugs prevent cell division or cause cell death.1 They act predominantly on rapidly dividing cells such as T lymphocytes, and are therefore immunosuppressive and anti-inflammatory.1 When cytotoxic drugs were initially used in the treatment of cancer, it became apparent that they had profound effects on the immune system. This “unwanted” side effect has subsequently been exploited for the treatment of non-malignant disease where autoimmune mechanisms are considered important in the pathogenesis.2 More recently drugs such as cyclosporine, which act more specifically on the immune system via the inhibition of T lymphocyte function, are being used for the treatment of disease with immunologically mediated mechanisms.Generally speaking cytotoxic drugs (CDs) have anticancer activity as well as immunosuppressive properties, whereas immunosuppressive drugs (ISDs) show a more specific immunosuppressive effect, although this distinction is partly arbitrary. For the purposes of this review we have adopted the classification described in the British National Formulary defining cyclosporine as an ISD; cyclophosphamide, vincristine, chlorambucil, and methotrexate as CDs; and azathioprine (and its active metabolite 6-mercaptopurine) and mycophenolate mofetil as “cytotoxic immunosuppressants”.This review concentrates on the use of ISDs and CDs in the management of vasculitis and rheumatological disease, idiopathic nephrotic syndrome, and inflammatory bowel disease. For the majority of the disorders discussed treatment with ISDs and CDs will usually be initiated by clinicians with experience of the condition.Reference to efficacy and safety of ISDs and CDs in children will be made. Specifically, the use of ISDs and CDs in organ transplantation will not be addressed.CDs act primarily on rapidly dividing cells such as malignant cells, or those of the immune system, particularly T lymphocytes.1 Thus CDs have both anti-inflammatory and immunosuppressive effects. Azathioprine (and its metabolite 6-mercaptopurine) and mycophenolate mofetil inhibit biosynthesis of purines and act during the …" @default.
• W2154462017 created "2016-06-24" @default.
• W2154462017 creator A5059983393 @default.
• W2154462017 date "2000-09-01" @default.
• W2154462017 modified "2023-10-15" @default.
• W2154462017 title "Personal practice: The use of immunosuppressive and cytotoxic drugs in non-malignant disease" @default.
• W2154462017 cites W1480890673 @default.
• W2154462017 cites W1579033217 @default.
• W2154462017 cites W191284583 @default.
• W2154462017 cites W1935701701 @default.
• W2154462017 cites W1966746905 @default.
• W2154462017 cites W1971058219 @default.
• W2154462017 cites W1975272198 @default.
• W2154462017 cites W1977248499 @default.
• W2154462017 cites W1981507875 @default.
• W2154462017 cites W1982383113 @default.
• W2154462017 cites W1988427509 @default.
• W2154462017 cites W1991424294 @default.
• W2154462017 cites W1995616322 @default.
• W2154462017 cites W2007198494 @default.
• W2154462017 cites W2010682176 @default.
• W2154462017 cites W2024293518 @default.
• W2154462017 cites W2027272349 @default.
• W2154462017 cites W2031049798 @default.
• W2154462017 cites W2037547791 @default.
• W2154462017 cites W2038919542 @default.
• W2154462017 cites W2040395702 @default.
• W2154462017 cites W2040741242 @default.
• W2154462017 cites W2043723211 @default.
• W2154462017 cites W2045138945 @default.
• W2154462017 cites W2049183041 @default.
• W2154462017 cites W2054178361 @default.
• W2154462017 cites W2054708657 @default.
• W2154462017 cites W2057749114 @default.
• W2154462017 cites W2060930927 @default.
• W2154462017 cites W206197658 @default.
• W2154462017 cites W2065541718 @default.
• W2154462017 cites W2067006054 @default.
• W2154462017 cites W2088121986 @default.
• W2154462017 cites W2104155486 @default.
• W2154462017 cites W2126493213 @default.
• W2154462017 cites W2134772591 @default.
• W2154462017 cites W2145870041 @default.
• W2154462017 cites W2147603018 @default.
• W2154462017 cites W2152588489 @default.
• W2154462017 cites W2156597637 @default.
• W2154462017 cites W2260844430 @default.
• W2154462017 cites W2312254946 @default.
• W2154462017 cites W2316086035 @default.
• W2154462017 cites W2325870812 @default.
• W2154462017 cites W2326745462 @default.
• W2154462017 cites W2334439890 @default.
• W2154462017 cites W2336764264 @default.
• W2154462017 cites W2342174771 @default.
• W2154462017 cites W2407365926 @default.
• W2154462017 cites W2407611832 @default.
• W2154462017 cites W2409267346 @default.
• W2154462017 cites W2414127876 @default.
• W2154462017 cites W2417042098 @default.
• W2154462017 cites W2417404210 @default.
• W2154462017 cites W2460516514 @default.
• W2154462017 cites W4254230446 @default.
• W2154462017 cites W4290135206 @default.
• W2154462017 doi "https://doi.org/10.1136/adc.83.3.259" @default.
• W2154462017 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1718468" @default.
• W2154462017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10952651" @default.
• W2154462017 hasPublicationYear "2000" @default.
• W2154462017 type Work @default.
• W2154462017 sameAs 2154462017 @default.
• W2154462017 citedByCount "32" @default.
• W2154462017 countsByYear W21544620172012 @default.
• W2154462017 countsByYear W21544620172013 @default.
• W2154462017 countsByYear W21544620172015 @default.
• W2154462017 countsByYear W21544620172017 @default.
• W2154462017 countsByYear W21544620172018 @default.
• W2154462017 countsByYear W21544620172019 @default.
• W2154462017 countsByYear W21544620172022 @default.
• W2154462017 countsByYear W21544620172023 @default.
• W2154462017 crossrefType "journal-article" @default.
• W2154462017 hasAuthorship W2154462017A5059983393 @default.
• W2154462017 hasBestOaLocation W21544620171 @default.
• W2154462017 hasConcept C121608353 @default.
• W2154462017 hasConcept C126322002 @default.
• W2154462017 hasConcept C154317977 @default.
• W2154462017 hasConcept C177713679 @default.
• W2154462017 hasConcept C185592680 @default.
• W2154462017 hasConcept C202751555 @default.
• W2154462017 hasConcept C203014093 @default.
• W2154462017 hasConcept C2779134260 @default.
• W2154462017 hasConcept C3017722815 @default.
• W2154462017 hasConcept C55493867 @default.
• W2154462017 hasConcept C71924100 @default.
• W2154462017 hasConceptScore W2154462017C121608353 @default.
• W2154462017 hasConceptScore W2154462017C126322002 @default.
• W2154462017 hasConceptScore W2154462017C154317977 @default.
• W2154462017 hasConceptScore W2154462017C177713679 @default.
• W2154462017 hasConceptScore W2154462017C185592680 @default.
• W2154462017 hasConceptScore W2154462017C202751555 @default.

• next